Pathania A, Prathipati P, Olwenyi O, Chava S, Smith O, Gupta S, et al. miR-15a and miR-15b modulate natural killer and CD8+T-cell activation and anti-tumor immune response by targeting PD-L1 in neuroblastoma. Mol Ther Oncolytics. 2022;25:308-329 pubmed publisher

Bates P, Rakhmilevich A, Cho M, Bouchlaka M, Rao S, Hales J, et al. Combining Immunocytokine and Ex Vivo Activated NK Cells as a Platform for Enhancing Graft-Versus-Tumor Effects Against GD2+ Murine Neuroblastoma. Front Immunol. 2021;12:668307 pubmed publisher

Magee K, Marsh I, Turek M, Grudzinski J, Aluicio Sarduy E, Engle J, et al. Safety and feasibility of an in situ vaccination and immunomodulatory targeted radionuclide combination immuno-radiotherapy approach in a comparative (companion dog) setting. PLoS ONE. 2021;16:e0255798 pubmed publisher

Brignole C, Bensa V, Fonseca N, Del Zotto G, Bruno S, Cruz A, et al. Cell surface Nucleolin represents a novel cellular target for neuroblastoma therapy. J Exp Clin Cancer Res. 2021;40:180 pubmed publisher

Strobel S, Machiraju D, Hülsmeyer I, Becker J, Paschen A, Jager D, et al. Expression of Potential Targets for Cell-Based Therapies on Melanoma Cells. Life (Basel). 2021;11: pubmed publisher

Baniel C, Sumiec E, Hank J, Bates A, Erbe A, Pieper A, et al. Intratumoral injection reduces toxicity and antibody-mediated neutralization of immunocytokine in a mouse melanoma model. J Immunother Cancer. 2020;8: pubmed publisher

Baniel C, Heinze C, Hoefges A, Sumiec E, Hank J, Carlson P, et al. In situ Vaccine Plus Checkpoint Blockade Induces Memory Humoral Response. Front Immunol. 2020;11:1610 pubmed publisher

Voeller J, Erbe A, Slowinski J, Rasmussen K, Carlson P, Hoefges A, et al. Combined innate and adaptive immunotherapy overcomes resistance of immunologically cold syngeneic murine neuroblastoma to checkpoint inhibition. J Immunother Cancer. 2019;7:344 pubmed publisher

Barton J, Pacey K, Jain N, Kasia T, Edwards D, Thevanesan C, et al. Establishment and phenotyping of neurosphere cultures from primary neuroblastoma samples. F1000Res. 2019;8:823 pubmed publisher

Morris Z, Guy E, Werner L, Carlson P, Heinze C, Kler J, et al. Tumor-Specific Inhibition of In Situ Vaccination by Distant Untreated Tumor Sites. Cancer Immunol Res. 2018;6:825-834 pubmed publisher

RICHMAN S, Nunez Cruz S, Moghimi B, Li L, Gershenson Z, Mourelatos Z, et al. High-Affinity GD2-Specific CAR T Cells Induce Fatal Encephalitis in a Preclinical Neuroblastoma Model. Cancer Immunol Res. 2018;6:36-46 pubmed publisher

Fisher J, Abramowski P, Wisidagamage Don N, Flutter B, Capsomidis A, Cheung G, et al. Avoidance of On-Target Off-Tumor Activation Using a Co-stimulation-Only Chimeric Antigen Receptor. Mol Ther. 2017;25:1234-1247 pubmed publisher